Onderneming TCR2 Therapeutics Inc.
Aandelen
TCRR
US87808K1060
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 58
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 01-01-16 |
William Bertrand
PSD | President | 59 | 01-06-23 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Praveen Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Peter Olagunju
COO | Chief Operating Officer | - | 20-07-21 |
Carl F. Mauch
IRC | Investor Relations Contact | - | - |
Kevin Zikaras
PRN | Corporate Officer/Principal | - | 01-06-18 |
Richard Roomberg
AUD | Comptroller/Controller/Auditor | - | 01-01-19 |
Margaret Siegel
LAW | General Counsel | - | 01-01-18 |
Corporate Officer/Principal | 41 | 01-01-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 01-01-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 39 261 745 | 38 342 495 ( 97,66 %) | 0 | 97,66 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,42% | 41,52 mld. | |
+42,15% | 39,9 mld. | |
+1,97% | 38,83 mld. | |
-14,19% | 26,05 mld. | |
+1,82% | 23,78 mld. | |
-24,55% | 18,26 mld. | |
-4,07% | 11,65 mld. | |
+21,36% | 11,53 mld. | |
+8,20% | 11,2 mld. |